Table 4.
Characteristic | CA-anxiety present n = 1586 n (%) |
CA-anxiety absent n = 68 657 n (%) |
P |
---|---|---|---|
Sex | |||
Male | 511 (32.2) | 34 527 (50.3) | <.001 |
Female | 1075 (67.8) | 34 130 (49.7) | |
Diagnosis | |||
Lymphoma | 990 (62.4) | 42 659 (62.1) | <.001 |
Myeloma | 309 (19.5) | 11 834 (17.2) | |
Leukemia | 189 (11.9) | 7 915 (11.5) | |
Myelodysplastic syndromes | 98 (6.2) | 6 249 (9.1) | |
Age (y) | |||
67-69 | 217 (13.7) | 8 038 (11.7) | <.001 |
70-74 | 428 (27.0) | 15 695 (22.9) | |
75-79 | 378 (23.8) | 16 841 (24.5) | |
≥80 | 563 (35.5) | 28 083 (40.9) | |
Race | |||
White | 1457 (91.9) | 61 084 (89.0) | <.001 |
Non-White | 129 (8.1) | 7 573 (11.0) | |
Marital status | |||
Married | 777 (49.0) | 35 749 (52.1) | .016 |
Not married | 809 (51.0) | 32 908 (47.9) | |
Residency | |||
Urban | 1547 (97.5) | 67 213 (97.9) | .376 |
Rural | 39 (2.5) | 1 444 (2.1) | |
Education (census tract quintile) * | |||
1 (lowest) | 331 (20.9) | 14 932 (21.7) | .142 |
2 | 285 (18.0) | 13 493 (19.7) | |
3 | 302 (19.0) | 13 411 (19.5) | |
4 | 341 (21.5) | 13 459 (19.6) | |
5 (highest) | 327 (20.6) | 13 362 (19.5) | |
Median income (census tract quintile)† | |||
1 (lowest) | 373 (23.5) | 13 950 (20.3) | .002 |
2 | 323 (20.4) | 13 280 (19.3) | |
3 | 316 (19.9) | 13 451 (19.6) | |
4 | 292 (18.4) | 13 722 (20.0) | |
5 (highest) | 282 (17.8) | 14 254 (20.8) | |
Surveillance, Epidemiology, and End Results registry region | |||
Midwest | 195 (12.3) | 9 105 (13.3) | <.001 |
Northeast | 288 (18.2) | 17 500 (25.5) | |
South | 501 (31.6) | 16 058 (23.4) | |
West | 602 (38.0) | 25 994 (37.9) | |
Year of diagnosis | |||
2000-2003 | 267 (16.8) | 16 639 (24.2) | <.001 |
2004-2007 | 344 (21.7) | 18 180 (26.5) | |
2008-2011 | 430 (27.1) | 17 490 (25.5) | |
2012-2015 | 545 (34.4) | 16 348 (23.8) | |
Charlson comorbidity score | |||
0 | 797 (50.3) | 34 899 (50.8) | .662 |
1 | 393 (24.8) | 16 340 (23.8) | |
2+ | 396 (25.0) | 17 418 (25.4) | |
Precancer depression | |||
Absent | 1297 (81.8) | 64 055 (93.3) | <.001 |
Present | 289 (18.2) | 4 602 (6.7) |
See Table 1 footnotes.